VAERS Explorer
Back to explore

Report #2832742

Received Mar 24, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
IA
Recovered
Unknown
Vaccinated
Mar 3, 2025
Onset
Mar 3, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
MMRVMEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD)MERCK & CO. INC.UNKX021757OT

Symptoms (2)

Expired product administeredNo adverse event

Symptom narrative

Caller reported expired dose of PROQUAD was administered. No other information provided. No additional AEs/PQC reported.; No additional AEs/PQC reported; This spontaneous report was received from a Nurse and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 03-Mar-2025, the was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), formulation: injection, lot #X021757, expiration date: 23-Feb-2025, 0.5 mL, administered by subcutaneous route (anatomical location was not provided) for prophylaxis. The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT) (lot # and expiration date were not provided) (expired vaccine used). No additional adverse events reported (no adverse event).

Other medications

MERCK STERILE DILUENT